Try Alerts Free   |   Login
› SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Zymergen (ZY) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 3 quarters since 2021. Compare with ZY stock chart to see long term trends.

ZY Stock Compared to Quarterly

ZY Income Statement

Revenue, Net:4082000
Revenue Per Share:0.04
Cost of Goods & Services Sold:17179000
Selling, General & Admin Expense:3977000
Research & Development Expense:39073000
Total Operating Expenses:99328000
Operating Income:-98247000
Income Taxes:-18000
Net Income:-98229000
Earnings Per Share, Basic:-0.96
Shares Outstanding, Basic Avg:102400795

ZY Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:5799000
Change in Accounts Receiveable:-4056000
Net Cash from Operations:-70536000
Net Cash from Financing Activities:-3125000
Property, Plant & Equipment Purchases:7701000
Net Cash from Investing Activities:-7701000
Net Change in Cash & Equivalents:-81484000

ZY Balance Sheet

Cash and Cash Equivalents:507054000
Inventories:6210000
Total Current Assets:516564000
Property, Plant & Equipment, Net:54572000
Total Assets:627336000
Accounts Payable:10472000
Current Portion of Long-Term Debt:80221000
Total Short-Term Liabilities:120652000
Long Term Debt, Non-Current Portion:0
Total Liabilities:150520000

Insider Trading

Change
Value
Transaction
SEC Form 4
FLATLEY JAY T   Chairman and Acting CEO
100,000 sh at $10
$1,000,000
Buy

Data imported from Zymergen Inc. SEC filings. Check original filings before making any investment decision.